Academic Journals Database
Disseminating quality controlled scientific knowledge

Search Articles for "Fenofibrate"

ADD TO MY LIST
 
Fenofibrate monotherapy-induced rhabdomyolysis in a patient with type-2 diabetes

Author(s): Cetinkaya Ramazan | Uyanik Abdullah | Yildirim Rahsan | Bilen Yusuf | Keles Mustafa
Treatment of hypertriglyceridemia and HIV: fenofibrate-induced changes in the expression of chemokine genes in circulating leukocytes

Author(s): Alonso-Villaverde Carlos | Aragonès Gerard | Beltrán-Debón Raúl | Fernández-Sender Laura | Rull Anna | Camps Jordi | Alegret Josep | Joven Jorge
Acute renal failure due to fenofibrate monotherapy

Author(s): Döndü Üsküdar Cansu | Nazife Şule Yaşar | Cengiz Korkmaz
Combination drug treatment in obese diabetic patients

Author(s): Theodosios D Filippatos | Moses S Elisaf
Hyperlipidemia related to the use of HIV-protease inhibitors: natural history and results of treatment with fenofibrate

Author(s): Caramelli Bruno | Bernoche Claudia Y.S.M. de | Sartori Ana M. C. | Sposito Andrei C. | Santos Raul D. | Monachini Maristela C. | Strabelli Tania | Uip Davi
Fenofibrate-induced myopathy

Author(s): Ghosh Bhaskar | Sengupta S | Bhattacharjee B | Majumder A | Sarkar S
In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer

Author(s): Saidi Samir | Holland Cathrine | Charnock-Jones D Stephen | Smith Stephen
METHOD DEVELOPMENT AND VALIDATION OF FENOFIBRATE BY HPLC USING HUMAN PLASMA

Author(s): M.T. Zzaman | S.A. Khan | A. Arora | O. Ahmad 2
Fenofibrate Treatment Enhances Antioxidant Status and Attenuates Endothelial Dysfunction in Streptozotocin-Induced Diabetic Rats

Author(s): Murat Olukman | Ebru Demirel Sezer | Sibel Ülker | Eser Y. Sözmen | Gülcihan Mehtap Çınar
Diabetic cardiomyopathy: effects of fenofibrate and metformin in an experimental model – the Zucker diabetic rat

Author(s): Forcheron Fabien | Basset Alexandra | Abdallah Pauline | Del Carmine Peggy | Gadot Nicolas | Beylot Michel
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone

Author(s): Syversen Unni | Stunes Astrid | Gustafsson Björn | Obrant Karl | Nordsletten Lars | Berge Rolf | Thommesen Liv | Reseland Janne
Suggestion for linkage of chromosome 1p35.2 and 3q28 to plasma adiponectin concentrations in the GOLDN Study

Author(s): Rasmussen-Torvik Laura | Pankow James | Peacock James | Borecki Ingrid | Hixson James | Tsai Michael | Kabagambe Edmond | Arnett Donna
Enhancement of dissolution of Fenofibrate by Solid dispersion Technique

Author(s): Tejas Patel | L. D Patel | Timir Patel | Sunil Makwana | Tushar Patel
ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARα -mediated inhibition of Glioma cell motility in vitro

Author(s): Drukala Justyna | Urbanska Katarzyna | Wilk Anna | Grabacka Maja | Wybieralska Ewa | Del Valle Luis | Madeja Zbigniew | Reiss Krzysztof
Effects of fenofibrate on lipid profiles, cholesterol ester transfer activity, and in-stent intimal hyperplasia in patients after elective coronary stenting

Author(s): Miyazaki Tetsuro | Shimada Kazunori | Miyauchi Katsumi | Kume Atsumi | Tanimoto Kosei | Kiyanagi Takashi | Sumiyoshi Katsuhiko | Hiki Makoto | Mokuno Hiroshi | Okazaki Shinya | Sato Hitoshi | Kurata Takeshi | Daida Hiroyuki
In vivo Evaluation of PPAR-α and PPAR-γ Agonist in Hyperlipidemia Induced Wister Albino Rats

Author(s): J. Suresh | S. Satish | M.N. Mahesh | K.S. Santilna | K. Mruthunjaya
Combination drug treatment in patients with non-alcoholic fatty liver disease

Author(s): Theodosios D Filippatos, Moses S Elisaf
Hypoglycemic and Hypolipidemic Effect of Sida rhombifolia ssp. retusa in Diabetic Induced Animals

Author(s): Kamlesh Dhalwal | Vaibhav M. Shinde | Bhagat Singh | Kakasaheb R. Mahadik
Activation of the peroxisome proliferator-activated receptor α protects against myocardial ischaemic injury and improves endothelial vasodilatation

Author(s): Tabernero Antonia | Schoonjans Kristina | Jesel Laurence | Carpusca Irina | Auwerx Johan | Andriantsitohaina Ramaroson
Molecular cloning, gene structure and expression profile of two mouse peroxisomal 3-ketoacyl-CoA thiolase genes

Author(s): Chevillard Grégory | Clémencet Marie-Claude | Etienne Philippe | Martin Pascal | Pineau Thierry | Latruffe Norbert | Nicolas-Francès Valérie
PPARα downregulates airway inflammation induced by lipopolysaccharide in the mouse

Author(s): Delayre-Orthez Carine | Becker Julien | Guenon Isabelle | Lagente Vincent | Auwerx Johan | Frossard Nelly | Pons Françoise
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins

Author(s): Tenenbaum Alexander | Fisman Enrique | Motro Michael | Adler Yehuda
Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials

Author(s): Liu Jianping | Zhang Jing | Shi Yi | Grimsgaard Sameline | Alraek Terje | Fønnebø Vinjar
Are HIV positive patients resistant to statin therapy?

Author(s): Johns Kevin | Bennett Matthew | Bondy Gregory
Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study

Author(s): Cindoruk Mehmet | Kerem Mustafa | Karakan Tarkan | Salman Bulent | Akin Okan | Alper Murat | Erdem Ozlem | Ünal Selahattin
A comparative study on the effects of niacin plus atorvastatin with that of fenofibrate plus atorvastatin in dyslipidemia

Author(s): Salim Ahmed | A.K.M. Mosharrof Hossain | Sudhangshu Ranjan Dey | A.K.M. Akhtaruzzaman | Musammath Moriom Siddika
Plasma PCSK9 levels are significantly modified by statins and fibrates in humans

Author(s): Mayne Janice | Dewpura Thilina | Raymond Angela | Cousins Marion | Chaplin Anna | Lahey Karen | LaHaye Stephen | Mbikay Majambu | Ooi Teik | Chrétien Michel
Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?

Author(s): Roberto Scatena | Patrizia Bottoni | Bruno Giardina
PPAR-α Agonist Fenofibrate Upregulates Tetrahydrobiopterin Level through Increasing the Expression of Guanosine 5′-Triphosphate Cyclohydrolase-I in Human Umbilical Vein Endothelial Cells

Author(s): Jinbo Liu | Changlin Lu | Fuwang Li | Haining Wang | Liyun He | Yanting Hao | Alex F. Chen | Huijie An | Xian Wang | Tianpei Hong | Guang Wang
Rosiglitazone and Fenofibrate Additive Effects on Lipids

Author(s): Ahmad Slim | Laudino Castillo-Rojas | Eddie Hulten | Jennifer N. Slim | Dorette Pearce Moore | Todd C. Villines
Pharmacological Screening of Annona cherimola for Antihyperlipidemic Potential

Author(s): Adarsh Verma M | Ajay Kumar P | Raja Shekar K | Kranthi Kumar A | Chakrapani | Roja Rani A
A Stability Indicating HPLC method with Diode Array Detection for the Determination of Atorvastatin Calcium and Fenofibrate in Commercial Tablets

Author(s): M. Sudheer*1, M. Siva Prakash, G. Rajashekar, K. V. Hima Vani, P. Ramalingam, Y. Padmanabha Reddy
Determination of Fenofibrate and the Degradation Product Using Simultaneous UV-Derivative Spectrometric Method and HPLC

Author(s): Fathy M. M. Salamaa | Mohamed W. I. Nassar | Mohie M. K. Sharaf El-Din | Khalid A. M. Attia | Mohamed Yousri Kaddah
In Vitro Competitive Metabolism Study of Olmesartan Medoxomil in Rat Liver S9 Fractions Using LC/MS

Author(s): M. Gandhimathi | Rahul Baghla | S. Subramanian | T.K Ravi
Simultaneous Estimation of Rosuvastatin Calcium and Fenofibrate in Bulk and in Tablet Dosage Form by UV-Spectrophotometry and RP-HPLC

Author(s): Anandakumar Karunakaran | Vetsa Subhash | Ramu Chinthala | Jayamaryapan Muthuvijayan
Solubility enhancement and solid state characterization of fenofibrate solid dispersions with polyethylene glycol 6000 and 8000

Author(s): Anjan K. Mahapatra1,*, Padala Narasimha Murthy2, Jagannath Sahoo2, Siba Prasad Pradhan3, Ruchita Kumari Patra1
Three simple spectrometric methods for fenofibrate in tablet form

Author(s): Preeti Vinod Gaikwad*, Sanjay Dinkar Sawant, Minal Rushikesh Ghante, Neha Manish Munot
Additional Treatment with Fenofibrate for Patients Treated with Pitavastatin Under Ordinary Medical Practice for Hypertriglyceridemia in Japan (APPROACH-J Study)

Author(s): Yasushi Wakida | Satoshi Suzuki, | Hirohiko Nomura, | on behalf of APPROACH-J Investigators | Tatsuya Isomura
A case of rhabdomyolysis due to fenofibrate use

Author(s): Tamer Yazar | Yusuf Kayran | Murat Çabalar | Ayla Çulha | Vildan Yayla
A Systems Biology Strategy for Predicting Similarities and Differences of Drug Effects: Evidence for Drug-specific Modulation of Inflammation in Atherosclerosis

Author(s): Kleemann Robert | Bureeva Svetlana | Perlina Ally | Kaput Jim | Verschuren Lars | Wielinga Peter | Hurt-Camejo Eva | Nikolsky Yuri | van Ommen Ben | Kooistra Teake
The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats

Author(s): Stunes Astrid | Westbroek Irene | Gustafsson Björn | Fossmark Reidar | Waarsing Jan | Eriksen Erik | Petzold Christiane | Reseland Janne | Syversen Unni
Why do you need a reservation system?      Affiliate Program